Advocacy intelligence hub — real-time data for patient organizations
Başakşehir Çam & Sakura City Hospital
Debiopharm International SA — PHASE3
Alexion Pharmaceuticals, Inc. — PHASE2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IRCCS San Raffaele
IRCCS San Raffaele
Erasmus Medical Center — NA
IRCCS San Raffaele
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance6
Patient Assistance Programs2
Sandostatin LAR
Novartis Pharmaceuticals Corporation
Palsonify
Crinetics Pharmaceuticals, Inc.
Palsonify
(paltusotine)Orphan drugCrinetics Pharmaceuticals, Inc.
12.1 Mechanism of Action Similar to the natural hormone somatostatin, paltusotine suppresses growth hormone (GH) and insulin-like growth factor-1 (IGF...
Somavert
(Pegvisomant)Orphan drugSensus Corporation
12.1 Mechanism of Action Pegvisomant selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of endogenous GH...
Sandostatin LAR
(Octreotide)Orphan drugstandardNovartis Pharmaceuticals Corporation
12.1 Mechanism of Action Octreotide exerts pharmacologic actions similar to the natural hormone, somatostatin. It is an even more potent inhibitor of ...
Somatuline Depot
(Lanreotide)Orphan drugstandardIPSEN, Inc.
12.1 Mechanism of Action Lanreotide, the active component of SOMATULINE DEPOT is an octapeptide analog of natural somatostatin. The mechanism of actio...
Pamela U Freda, MD, M.D
Columbia University
📍 NEW YORK, NY
Jens Otto L Jørgensen, MD
Medical department M, Århus University Hospital
Annamaria Colao, MD
Federico II University
Shlomo Melmed, MD, M.D
Cedars-Sinai Medical Center, Pituitary Center
📍 LOS ANGELES, CA
Peter KAMENICKY, MD
Assistance Publique Hopitaux de Paris
Jochen Schopohl, MD
Medizinische Klinik - Innenstadt